LINDSAY RIECK: Open Payments
NPI 1649613316 · HARRISBURG, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 35 payments from 11 companies in 2025. Trend: 2023 $282 · 2024 $326 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $146 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| PFIZER INC. | 3 | $50 |
| Paratek Pharmaceuticals, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Auvelity, VRAYLAR, XIFAXAN, NURTEC ODT, UBRELVY, NUZYRA, GVOKE HYPOPEN, QULIPTA.
Industry payments across SD — which companies pay providers there.
